Allergan Sales, LLC recalls Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023…
- Recall date
- October 19, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0077-2018
- FDA classification
- Class III
- Brand / firm
- Allergan Sales, LLC
- Sold / distributed
- Nationwide and Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.
Why it was recalled
Failed Impurities/Degradation Specifications.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03; b) 5 mL (NDC# 0023-9211-05); c) 10 mL (NDC# 0023-9211-10); d) 15 mL (NDC# 0023-9211-15) bottles, Manufactured By: Allergan, Irvine, CA 92612..
Get recall alerts
Free email alert whenever Allergan Sales, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Allergan Sales, LLC